Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/14/2025 | $93.00 | Buy → Hold | Melius |
| 11/18/2024 | $112.00 → $107.00 | Buy → Hold | Stifel |
| 11/13/2024 | $102.00 → $124.00 | Buy | UBS |
| 9/6/2024 | $97.00 | Equal-Weight | Morgan Stanley |
| 6/21/2024 | $110.00 | Buy | Jefferies |
| 3/12/2024 | $92.00 | Neutral | Exane BNP Paribas |
| 2/20/2024 | $81.00 → $89.00 | Outperform → In-line | Evercore ISI |
| 10/24/2023 | $73.00 | Hold → Buy | Stifel |
8-K - Ingersoll Rand Inc. (0001699150) (Filer)
8-K - Ingersoll Rand Inc. (0001699150) (Filer)
SCHEDULE 13G/A - Ingersoll Rand Inc. (0001699150) (Subject)
Well-positioned for strong operational performance in 2026 Fourth Quarter 2025 Highlights (All comparisons against the fourth quarter of 2024 and results are as reported unless otherwise noted) Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX): Orders of $1,952 million, up 8% Revenues of $2,091 million, up 10% Net income attributable to Ingersoll Rand Inc. of $266 million, $0.67 per share Adjusted net income attributable to Ingersoll Rand Inc.1 of $382 million, $0.96 per share, up 14% Adjusted EBITDA1 of $580 million, up 9%, with a margin of 27.7% Operating cash flow of $499 million and free cash flow1 of $462 m
DAVIDSON, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 26, 2026, to stockholders of record on March 4, 2026. About Ingersoll Rand Inc.Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and ind
DAVIDSON, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, will participate in fireside chats at the following upcoming investor conferences: The Barclays Industrial Select Conference on Wednesday, February 18, 2026, at 9:50 a.m. Eastern Time. The Citi Global Industrial Tech and Mobility Conference on Thursday, February 19, 2026, at 8:50 a.m. Eastern Time. A real-time audio webcast of both fireside chats can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website here. A replay
4 - Ingersoll Rand Inc. (0001699150) (Issuer)
4 - Ingersoll Rand Inc. (0001699150) (Issuer)
4 - Ingersoll Rand Inc. (0001699150) (Issuer)
Melius downgraded Ingersoll-Rand from Buy to Hold and set a new price target of $93.00
Stifel downgraded Ingersoll-Rand from Buy to Hold and set a new price target of $107.00 from $112.00 previously
UBS resumed coverage of Ingersoll-Rand with a rating of Buy and set a new price target of $124.00 from $102.00 previously
Well-positioned for strong operational performance in 2026 Fourth Quarter 2025 Highlights (All comparisons against the fourth quarter of 2024 and results are as reported unless otherwise noted) Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX): Orders of $1,952 million, up 8% Revenues of $2,091 million, up 10% Net income attributable to Ingersoll Rand Inc. of $266 million, $0.67 per share Adjusted net income attributable to Ingersoll Rand Inc.1 of $382 million, $0.96 per share, up 14% Adjusted EBITDA1 of $580 million, up 9%, with a margin of 27.7% Operating cash flow of $499 million and free cash flow1 of $462 m
DAVIDSON, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 26, 2026, to stockholders of record on March 4, 2026. About Ingersoll Rand Inc.Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and ind
DAVIDSON, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, will issue its fourth quarter 2025 earnings release after the market closes on Thursday, February 12, 2026. Ingersoll Rand will also host a live earnings conference call to discuss the fourth quarter results on Friday, February 13, 2026, at 8 a.m. Eastern Time. To participate in the call, please dial +1-888-330-3073, domestically, or +1-646-960-0683, internationally, and use access code 8970061. A real-time audio webcast of the presentation can be accessed via the Events and Presentations section of the Ingersoll R
DAVIDSON, N.C., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Jerome Guillen to its Board of Directors, effective January 1, 2026. Guillen spent more than two decades in leadership positions in the automotive and transportation industries, most recently as a president at Tesla, Inc. He held functional leadership across engineering, sales, supply chain, and manufacturing, and played a key role in launching the Model S and Semi Truck programs, advancing production efficiency, automation, and sustainable technologies. Prior to Tesla, he held
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as
DAVIDSON, N.C., July 15, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Aurobind Satpathy to its Board of Directors, effective immediately. Satpathy currently serves as a senior partner at McKinsey & Company, a global management consulting firm. During his nearly 30-year career with McKinsey & Company, Satpathy led multi-billion-dollar mergers, guided companies through public-to-private transitions, and architected growth strategies that resulted in increases in market capitalization. In addition, Satpathy led global technology-enablement efforts wi
SC 13G/A - Ingersoll Rand Inc. (0001699150) (Subject)
SC 13G/A - Ingersoll Rand Inc. (0001699150) (Subject)
SC 13G - Ingersoll Rand Inc. (0001699150) (Subject)